Drawing for FINCERAMICA

USPTO serial 79195797

FINCERAMICA

Reviewed by CopyMark Law Group

Reg. 5477560Status 707Registered
Filing date
Status date
Registration date
May 29, 2018
Examiner
LORENZO, KATHLEEN H
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with FINCERAMICA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Boris Umansky

Boris Umansky Ladas & Parry LLP224 S. Michigan Avenue, Ste. 1600Chicago, IL 60604United States

Goods and services

ClassDescriptionStatusFirst use
005[Pharmaceuticals and/or biomedical preparations for chondral/osteochondral lesions, traumatology, arthroplasty revision, orthopaedic/spinal/dental therapy, bone cavity filling, cranioplasty, bone regeneration promotion; regenerative medicine preparations for chondral/osteochondral/bone lesions, traumatology, arthroplasty revision, orthopaedic/spinal/dental therapy, bone cavity filling, cranioplasty; products combined with use of cells and/or pharmaceutical drugs, namely, pharmaceutical and/or biomedical preparations for use as tissue substitutes and/or for drug delivery systems]SECTION 71 - CANCELLED—
010Synthetic implantable medical devices for medical-surgical use, namely, devices for chondral/osteochondral lesions, traumatology, [ arthroplasty revision, ] implantable device in orthopedic/[ spinal/dental ] surgery, bone cavity filling, cranioplasty; Synthetic implantable medical devices for the regeneration of bone defects; Synthetic implantable medical devices for the regeneration of cartilaginous defects; Synthetic implantable medical devices for the regeneration of osteocartilagineous defects; artificial filling materials for augmentation of bone tissue for medical purposes; bone substitutes for surgical use; Synthetic materials for bone [ and teeth ] reconstruction, namely, hydroxyapatite, substituted hydroxyapatite, biomaterial of calcium phosphate and/or collagen for reconstructive bone surgery; Synthetic implantable medical devices for the reconstruction of bone, cartilage or osteocartilage in orthopedic, [ spinal, dental, ] cranio-maxillo-facial surgery; [ orthopedic prostheses for hip, knee, ankle, shoulder, arm; ] implantable prosthetic devices of artificial material for joints; [ non-implantable medical devices for perfusion/mixing of biological fluids and filling materials; medical materials included in this class and medical devices for tissue engineering combined with use of cells and/or pharmaceutical drugs, namely, ] implantable chondrol/osteochondral scaffolds primarily comprised of synthetic materialsACTIVE—
042[ Medical research, surgical research, regenerative medicine research, tissue engineering research, research of the use of cells in medicine and surgery and analysis services related to the foregoing research services ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2026INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Apr 25, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 26, 2026INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 26, 2026INPCINVALIDATION PROCESSED—
Feb 5, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
Sep 28, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 25, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Aug 25, 202571.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Aug 13, 2025EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jul 17, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 13, 2025PR71POST REGISTRATION ACTION MAILED - SEC.71—
Dec 30, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 29, 2024ES71TEAS SECTION 71 RECEIVED—
Sep 28, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 11, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 11, 2018FIMPFINAL DISPOSITION PROCESSED—
Aug 29, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 29, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 27, 2018OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 11, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 11, 2018OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 9, 2018GPNXNOTIFICATION PROCESSED BY IB—
Feb 21, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 21, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 21, 2018NPUBNOTICE OF PUBLICATION—
Jan 29, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 10, 2018CNEAEXAMINERS AMENDMENT MAILED—
Jan 9, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jan 9, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 11, 2017CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 10, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 7, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 7, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 7, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 24, 2016RFNTREFUSAL PROCESSED BY IB—
Dec 7, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 7, 2016RFRRREFUSAL PROCESSED BY MPU—
Nov 24, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 23, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 19, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 15, 2016DOCKASSIGNED TO EXAMINER—
Nov 15, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 10, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance